Literature DB >> 23616242

High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.

Liyong Wang1, Karen Nuytemans, Guney Bademci, Cherylyn Jauregui, Eden R Martin, William K Scott, Jeffery M Vance, Stephan Zuchner.   

Abstract

A high density comparative genomic hybridization array was designed to evaluate CNVs in the genomic region of six familial PD genes in 181 PD cases and 67 controls. No CNV was found in PARK7, ATP13A2, PINK1, and LRRK2. Intronic-only CNVs were found in SNCA and PARK2 but were not associated with PD risk. A whole-gene duplication of SNCA was found in one case. The allele frequency of PARK2 exonic CNV is significantly higher in cases than in controls (P = 0.02), higher in early-onset (AAO ≤ 40) than in late-onset cases (P = 0.001), and higher in familial than in sporadic cases (P = 0.005). Except for single exon 2 duplications, all PARK2 exonic CNVs have different breakpoints, even when the same exon(s) were involved. In conclusion, except for SNCA and PARK2, CNVs are not a major contributing mechanism for the familial PD genes examined. The majority of PARK2 exonic CNVs are not recurrent.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  CGH; CNV; PARK2; Parkinson

Mesh:

Substances:

Year:  2013        PMID: 23616242      PMCID: PMC4464794          DOI: 10.1002/humu.22344

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

1.  Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.

Authors:  M Periquet; C Lücking; J Vaughan; V Bonifati; A Dürr; G De Michele; M Horstink; M Farrer; S N Illarioshkin; P Pollak; M Borg; C Brefel-Courbon; P Denefle; G Meco; T Gasser; M M Breteler; N Wood; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  2001-02-14       Impact factor: 11.025

2.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

3.  Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines.

Authors:  Jun Mitsui; Yuji Takahashi; Jun Goto; Hiroyuki Tomiyama; Shunpei Ishikawa; Hiroyo Yoshino; Narihiro Minami; David I Smith; Suzanne Lesage; Hiroyuki Aburatani; Ichizo Nishino; Alexis Brice; Nobutaka Hattori; Shoji Tsuji
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

4.  Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

Authors:  Kenya Nishioka; Shin Hayashi; Matthew J Farrer; Andrew B Singleton; Hiroyo Yoshino; Hisamasa Imai; Toshiaki Kitami; Kenichi Sato; Ryu Kuroda; Hiroyuki Tomiyama; Koichi Mizoguchi; Miho Murata; Tatsushi Toda; Issei Imoto; Johji Inazawa; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

5.  Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Authors:  Karen S Marder; Ming X Tang; Helen Mejia-Santana; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Andrew D Siderowf; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Barbara M Ross; Lucien J Cote; Steven Frucht; Blair Ford; Roy N Alcalay; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Gregory D Neils; Miguel Verbitsky; Sergey Kisselev; Elise Caccappolo; Ruth Ottman; Lorraine N Clark
Journal:  Arch Neurol       Date:  2010-06

6.  Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.

Authors:  Karen Nuytemans; Bram Meeus; David Crosiers; Nathalie Brouwers; Dirk Goossens; Sebastiaan Engelborghs; Philippe Pals; Barbara Pickut; Marleen Van den Broeck; Ellen Corsmit; Patrick Cras; Peter P De Deyn; Jurgen Del-Favero; Christine Van Broeckhoven; Jessie Theuns
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

7.  alpha-Synuclein gene duplication is present in sporadic Parkinson disease.

Authors:  T-B Ahn; S Y Kim; J Y Kim; S-S Park; D S Lee; H J Min; Y K Kim; S E Kim; J-M Kim; H-J Kim; J Cho; B S Jeon
Journal:  Neurology       Date:  2007-07-11       Impact factor: 9.910

8.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.

Authors:  Mei Sun; Jeanne C Latourelle; G Frederick Wooten; Mark F Lew; Christine Klein; Holly A Shill; Lawrence I Golbe; Margery H Mark; Brad A Racette; Joel S Perlmutter; Abbas Parsian; Mark Guttman; Garth Nicholson; Gang Xu; Jemma B Wilk; Marie H Saint-Hilaire; Anita L DeStefano; Ranjana Prakash; Sally Williamson; Oksana Suchowersky; Nancy Labelle; John H Growdon; Carlos Singer; Ray L Watts; Stefano Goldwurm; Gianni Pezzoli; Kenneth B Baker; Peter P Pramstaller; David J Burn; Patrick F Chinnery; Scott Sherman; Peter Vieregge; Irene Litvan; Tammy Gillis; Marcy E MacDonald; Richard H Myers; James F Gusella
Journal:  Arch Neurol       Date:  2006-06

Review 9.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

10.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Authors:  Nathan Pankratz; Jemma B Wilk; Jeanne C Latourelle; Anita L DeStefano; Cheryl Halter; Elizabeth W Pugh; Kimberly F Doheny; James F Gusella; William C Nichols; Tatiana Foroud; Richard H Myers
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

View more
  6 in total

1.  Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson's disease.

Authors:  Na Zhao; Jianqiu Xiao; Zhiyong Zheng; Guoqiang Fei; Feng Zhang; Lirong Jin; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2015-03-10       Impact factor: 5.203

Review 2.  The role of monogenic genes in idiopathic Parkinson's disease.

Authors:  Xylena Reed; Sara Bandrés-Ciga; Cornelis Blauwendraat; Mark R Cookson
Journal:  Neurobiol Dis       Date:  2018-11-15       Impact factor: 5.996

3.  Copy number gain of VCX, X-linked multi-copy gene, leads to cell proliferation and apoptosis during spermatogenesis.

Authors:  Juan Ji; Yufeng Qin; Rong Wang; Zhenyao Huang; Yan Zhang; Ran Zhou; Ling Song; Xiufeng Ling; Zhibin Hu; Dengshun Miao; Hongbing Shen; Yankai Xia; Xinru Wang; Chuncheng Lu
Journal:  Oncotarget       Date:  2016-11-29

Review 4.  Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach.

Authors:  Valentina La Cognata; Giovanna Morello; Velia D'Agata; Sebastiano Cavallaro
Journal:  Hum Genet       Date:  2016-11-28       Impact factor: 4.132

5.  A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson's disease.

Authors:  Valentina La Cognata; Giovanna Morello; Giulia Gentile; Velia D'Agata; Chiara Criscuolo; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2016-09-17       Impact factor: 2.660

6.  NeuroArray: A Customized aCGH for the Analysis of Copy Number Variations in Neurological Disorders.

Authors:  Valentina La Cognata; Giovanna Morello; Giulia Gentile; Francesca Cavalcanti; Rita Cittadella; Francesca Luisa Conforti; Elvira Valeria De Marco; Angela Magariello; Maria Muglia; Alessandra Patitucci; Patrizia Spadafora; Velia D'Agata; Martino Ruggieri; Sebastiano Cavallaro
Journal:  Curr Genomics       Date:  2018-09       Impact factor: 2.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.